COMPARATIVE ANALYSIS OF COMBINED COURSE OF CHRONIC HEPATITIS C AND HIV DEPENDING ON THE ROUTE OF INFECTION

N Sarsekeyeva1, B Kosherova1, N Tabagari-Bregvadze1

  • 1Karaganda State Medical University, Kazakhstan; D. Tvildiani Medical University, Tbilisi, Georgia.

Georgian Medical News
|October 21, 2015
PubMed

Insights

Hepatitis C virus (HCV) infection in HIV patients varies by transmission route. Sexually transmitted HCV often presents asymptomatically, while injecting drug use leads to more symptoms and active infection.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is prevalent in Human Immunodeficiency Virus (HIV)-infected individuals.
  • Co-infection presents significant public health challenges due to transmission routes like drug addiction and sexual contact.
  • Limited prevention strategies and treatment efficacy highlight the need to understand disease characteristics.

Purpose of the Study:

  • To investigate the clinical and laboratory features of chronic Hepatitis C virus (HCV) in HIV-infected patients.
  • To determine how the route of HCV infection influences disease presentation and progression in this population.

Main Methods:

  • Prospective, open-label, non-randomized study design.
  • Inclusion of 58 HIV-positive patients diagnosed with chronic HCV.
  • Diagnostic verification using immune blotting for HIV and enzyme immunoassay/PCR for HCV.

Main Results:

  • Patients infected with HCV via sexual transmission exhibited an asymptomatic disease course.
  • Injecting drug users with HCV/HIV co-infection demonstrated increased clinical symptoms.
  • Injecting drug users also showed a moderate level of infectious process activity compared to sexually infected patients.

Conclusions:

  • The route of Hepatitis C virus (HCV) infection significantly impacts the clinical presentation and disease activity in co-infected HIV patients.
  • Understanding transmission routes is crucial for tailoring management and predicting outcomes in HCV/HIV co-infection.
  • Further research into prevention and treatment strategies based on infection routes is warranted.